The Greatest Value of Personalized Medicine

Grant D. Lawless, RPh, MD, FACP

Video Categories: Value

Grant Lawless discusses the definition of value in personalized medicine from different perspectives
January 30, 2014

Providing the Right Information on Target Therapy to the Oncology Community

Dr Agarwala discusses the optimal approach to providing information on targeted therapies to the oncology community.

January 16, 2019

Navigating the CMS 14-Day Rule in Biomarker Testing

Drs. David Rimm and Roy Herbst review the problems with the CMS “14-Day Rule” since some of the multigene panel biomarker tests require 21 days or longer to complete.